These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6829073)

  • 1. Effect of in vitro cyclosporin. A treatment on human natural and antibody-dependent cell-mediated cytotoxicity.
    Shao-Hsien C; Lang I; Gunn H; Lydyard P
    Transplantation; 1983 Feb; 35(2):127-9. PubMed ID: 6829073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mouse natural killer activity by cyclosporin A.
    Yanagihara RH; Adler WH
    Immunology; 1982 Feb; 45(2):325-32. PubMed ID: 6460686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory effects of corticosteroids on natural killer and antibody-dependent cellular cytotoxic activities of human lymphocytes.
    Nair MP; Schwartz SA
    J Immunol; 1984 Jun; 132(6):2876-82. PubMed ID: 6202765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes.
    Yano S; Sone S; Nishioka Y; Naito M; Tsuruo T; Ogura T
    Jpn J Cancer Res; 1994 Feb; 85(2):194-203. PubMed ID: 7511575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of alcohol and nicotine on cytotoxic functions of human lymphocytes.
    Nair MP; Kronfol ZA; Schwartz SA
    Clin Immunol Immunopathol; 1990 Mar; 54(3):395-409. PubMed ID: 1689229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysfunction of natural killer cells in multiple sclerosis: a possible pathogenetic factor.
    Benczur M; Petrányl GG; Pálffy G; Varga M; Tálas M; Kotsy B; Földes I; Hollán SR
    Clin Exp Immunol; 1980 Mar; 39(3):657-62. PubMed ID: 6155232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of histamine and histamine antagonists on natural and antibody-dependent cellular cytotoxicity of human lymphocytes in vitro.
    Nair MP; Schwartz SA
    Cell Immunol; 1983 Oct; 81(1):45-60. PubMed ID: 6225527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers.
    Sibbitt WL; Mathews PM; Bankhurst AD
    J Clin Invest; 1983 May; 71(5):1230-9. PubMed ID: 6853711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer (NK) and antibody-dependent cellular cytotoxicity (ADCC) activities can be differentiated by their different sensitivities to interferon and prostaglandin E1.
    Merrill JE
    J Clin Immunol; 1983 Jan; 3(1):42-50. PubMed ID: 6219125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human natural killer activity by cyclosporin A.
    Introna M; Allavena P; Spreafico F; Mantovani A
    Transplantation; 1981 Feb; 31(2):113-6. PubMed ID: 7256824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of natural killer and antibody-dependent cellular cytotoxicity by interferon and interleukin-2 in chronic myeloid leukemia patients in remission.
    Dabholkar M; Tatake R; Amin K; Advani S; Gangal S
    Oncology; 1989; 46(2):123-7. PubMed ID: 2785254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of intravenous immunoglobulin G on natural killer cell cytotoxicity in vitro in women with recurrent spontaneous abortion.
    Ruiz JE; Kwak JY; Baum L; Gilman-Sachs A; Beaman KD; Kim YB; Beer AE
    J Reprod Immunol; 1996 Aug; 31(1-2):125-41. PubMed ID: 8887127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of FK506 versus cyclosporine on human natural and antibody-dependent cytotoxicity reactions in vitro.
    Wasik M; Gorski A; Stepien-Sopniewska B; Lagodzinski Z
    Transplantation; 1991 Jan; 51(1):268-70. PubMed ID: 1702910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cadmium inhibits spontaneous (NK), antibody-mediated (ADCC) and IL-2-stimulated cytotoxic functions of natural killer cells.
    Cifone MG; Procopio A; Napolitano T; Alesse E; Santoni G; Santoni A
    Immunopharmacology; 1990; 20(2):73-80. PubMed ID: 2266002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of NK activity and antibody-dependent cellular cytotoxicity of lymphocytes by human tumor clonogenic assay--its correlation with the 51Cr-release assay.
    Nomori H; Saijo N; Fujita J; Hyoi M; Sasaki Y; Shimizu E; Kanzawa F; Inomata M; Hoshi A
    Int J Cancer; 1985 Apr; 35(4):449-55. PubMed ID: 3872846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
    Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
    Tomescu C; Tebas P; Montaner LJ
    AIDS; 2017 Mar; 31(5):613-622. PubMed ID: 28225449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporin A inhibition of interleukin 2 gene expression, but not natural killer cell proliferation, after interferon induction in vivo.
    Kasaian MT; Biron CA
    J Exp Med; 1990 Mar; 171(3):745-62. PubMed ID: 1689761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.